I  Georgia Research Alliance

http://www.gra.org





     Office Locations:

270 Peachtree Street NW, Suite 2200
Atlanta, GA 30303
Phone: 404-332-9770

 

Stages:

  • Early


 

Industries:

  • Defense & Homeland Security
  • Energy & Clean Tech
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial

  •  

    Description:

    GRA operates as an independent not-for-profit entity governed by leaders from industry and academia. While GRA receives a state appropriation for investment in university-based research opportunities, its small staff and lean operations are funded through foundation and industry contributions. GRA's venture development program is Georgia's only non-profit catalyst for seeding and shaping companies around research at multiple universities. GRA Venture Fund is a public-private venture capital fund investing in research-driven, Georgia-based startup companies. As one of the largest venture capital funds in Georgia, GRA Venture Fund is led by a team of professionals with deep experience and expertise in technology entrepreneurship. Today, 180 university-based companies are in the GRA portfolio. These enterprises have brought to Georgia more than a billion dollars in equity investment. They generate more than $660 million in revenue and employ more than 1300 professionals.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Amanda Schroeder VP
    Ashley F. Cornelison VP
    Greg Dane Senior Advisor
    H. Lee Herron DVM Sr. Vice President
    Susan G. Shows President and CEO

     

    Portfolio companies include:


      5M Biomedical


      Abby Med


      Abeome


      Accuitis


      Acivilate


      Adaptive Flight


      AgriThera


      Algix


      Antios Therapeutics
        web link


      Axion Biosystems
        web link


      BCARS


      Celtaxsys
        web link


      Clearside Biomedical
        web link


      EarliTec Diagnostics
        web link


      GeoVax


      IGED


      Lectenz


      Lucid Scientific


      NeurOp


      NovAb


      Nyra Medical


      OptiRTC
        web link


      Orko


      Proxime


      Reservoir


      Sanguina


     

    Recent News: